Recent breakthroughs in the field of obesity treatment have generated a new drug known as ALLUVI Retatrutide. This medication is a {highlypotent GLP-1 receptor agonist, engineered to amplify the effects of natural glucagon-like peptide-1. Retatrutide has shown remarkable results in clinical trials, demonstrating significant decreases in body weight